Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hainan Quanying Pharmaceutical is a comprehensive pharmaceutical enterprise based in Haikou, China, specializing in the research, development, and large-scale manufacturing of finished dosage forms. Established in 1993, the company has built a diverse portfolio primarily focused on anti-infectives, including cephalosporins and macrolides, as well as treatments for cardiovascular and gastrointestinal conditions. Its manufacturing facilities are located in the Haikou National High-tech Industrial Development Zone and are fully GMP-certified for the production of tablets, capsules, and granules. Hainan Quanying serves as both a domestic drug developer and a contract manufacturer, leveraging its regional presence to supply essential medicines across China. The company is recognized for its commitment to quality control and its role in the established pharmaceutical industrial cluster of Hainan Province.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hainan Quanying Pharmaceutical.